Remove 2022 Remove IPO Remove Valuation
article thumbnail

The 3rd Fintech Epoch: Europe’s first-movers drive M&A amid tightened purse strings

JD Supra: Mergers

UK & European Financial Services M&A: Sector trends H2 2022 | H1 2023 — Fintech - Whilst many European start-ups have struggled to successfully execute funding rounds at valuation levels of yesteryear, more mature fintechs have pivoted to acquisitions and partnerships to fuel growth. By: White & Case LLP

M&A 192
article thumbnail

Will the Downturn in IPOs and Valuations for Venture-Backed Technology Companies Lead to the Demise of Dual-Class Voting Structures?

JD Supra: Mergers

In this blog, we posit that “before” refers to the “bull market” that ended in January 2022, and “after” refers to everything that – happened, is happening, and will happen – next. History is often written by reference to “before” and “after.” By: Foley & Lardner LLP

IPO 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Will There Be an IPO for a Specialty Consulting Company in 2024?

Focus Investment Banking

It has taken two years to return to those levels, after 2022 and 2023 were burdened with interest rate hikes and fears of a recession. In that environment, very few firms sought IPOs, and there was a major slowdown in overall exits, whether private or public. The post Will There Be an IPO for a Specialty Consulting Company in 2024?

IPO 52
article thumbnail

Okay, which analyzes engineers’ productivity, sells to Stripe

TechCrunch: M&A

Financial terms of the deal, which marks Stripe’s first acquisition since it bought card reader provider BBPOS in January of 2022, were not disclosed. And Stripe, which has yet to go public via a long-awaited IPO, earlier this year raised $6.5 billion at a $50 billion valuation after being valued at $95 billion in March of 2021.

article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in. Let’s dig in.

M&A 40
article thumbnail

Upgrade acquires travel-focused BNPL startup Uplift for a song

TechCrunch: M&A

Uplift had raised nearly $700 million in equity and debt, securing $123 million at a reported $195 million valuation in its Series C round alone. Klarna , once Europe’s most valuable VC-backed company, suffered an 85% valuation cut, from $45.6 billion in July 2022 following an $800 million round. billion to just $6.7

Finance 219
article thumbnail

UK tech investment sees fall of 57 per cent

Growth Business

According to further figures from Dealroom , UK tech companies raised the most across Europe in 2022, securing $17.3bn in the first half of the year before the sector achieved combined market value of $1tn — meaning the UK had the most ground to lose.